Archean Chemical Industries Ltd.

Archean Chemical Industries Ltd.

439.45
INR
-3.95
(-0.89%)
7.99EPS
59.68P/E
60.16BMarket Cap
Feb 05Next Earn

Q4 FY2026 · Earnings Call TranscriptMay 13, 2026

Operator

Ladies and gentlemen, good day, and welcome to Archean Chemical Industries Limited Q4 FY '26 earnings conference call. As a reminder, all participant lines will be in the listen-only mode.

There will be an opportunity for you to ask questions after the presentation concludes. Should you need any assistance during this conference, please signal an operator by pressing star and then zero on your touch-tone telephones.

Please note that this conference is being recorded. I now hand the conference over to Mr.

Rampraveen Swaminathan, Managing Director of Archean Chemical. Thank you, and over to you, sir.

All

Rampraveen Swaminathan

right, good afternoon, everyone. Thank you for joining us here today, and a warm welcome to you all to our Q4 and FY '26 earnings call.

Thank you for taking the time once again to join us. I'm joined here today by Mr.

Natarajan Ramamurthy, CFO of the company; Mr. Rajeev Kumar, DGM Finance and Strategy; and our Investor Relations advisor SGA.

I hope you all had a chance to look through the financial results and the investor presentation which is available on our website and stock exchanges. I will provide an overview of the market conditions and external environment, cover some of the significant events in the past quarter, provide you a commentary on Q4 performance and FY '25-'26 performance, and outline some of our focus areas going forward.

Just beginning with the market, I think overall demand for our products from our end-key markets has been a mixed bag. For most of the year, demand from industrial salt has been muted, which has been reflected in a tough pricing environment for the product category, while demand for bromine and bromine derivatives has been positive in most geographies across the world.

Competitive intensity remains high, especially on salt, with increasing capacity in multiple regions and some more being added in FY '26 in Australia and some parts of the Middle East. The year that has gone by has also been marked by considerable uncertainty, volatility, and a continuously evolving external environment.

Several macroeconomic developments, including the India-US trade discussions, the India-EU FTA negotiations, tariffs imposed by the US government, and more recently, the Iran-US conflict, have influenced market dynamics across demand, supply, and pricing. While we have managed to navigate these conditions, the impact on our business cannot be overlooked.

Therefore, this year has been fairly skewed, with higher headwinds outweighing the positives, resulting in a constant focus on recalibrating the business operations. In Q4, we have seen a heightened impact due to the US-Iran crisis, and I'll cover that in more detail shortly.

Now, on a positive note, our key end customers and industry participants share our optimism about the future. We believe that in the categories we operate in, demand outlook in the medium term remains pretty positive, and we are very well-positioned in terms of our overall value package.

Looking at some key developments which have impacted our business during the quarter, let me first begin with our semiconductor business. Earlier this week, our subsidiary, SiCSem, has signed the Fiscal Support Agreement with the Government of India for our semiconductor project in Odisha.

This is a very important milestone for us as it now enables us to accelerate the financial closure and the execution of the project. Just to provide you a recap, we did do the groundbreaking ceremony at site in November, and we have teams which since then have been completing detailed engineering, finalizing supply partnerships, and doing resource development and deployment.

Overall, the program remains on track, and with the FSA, we hope to accelerate progress in the coming quarters. Another key development for us during the quarter was the impact of some changes in terms of bridges and road routifications in Kutch.

In the early part of Q4, the local administration of Gujarat has initiated road repairs and construction in a key stretch along the corridor from the Hajipir plant to the Jakhau and Mundra ports. As a result of that, we saw significant increase in distance of transportation, which has impacted our fleet availability due to higher TAT and fuel costs, as the distance effective distance increased by 2x.

As we stand right now, we understand this construction will continue till early Q3 of this financial year, after which we will be able to come back to more normal operations, both in terms of distance covered and TAT of our fleets. The third big thing which has impacted us in Q3 has been the Middle East crisis.

The US-Iran conflict has had an impact on demand, supply chain, volatility, and commodity costs in our business. The demand for bromine has increased sharply due to global demand-supply imbalance as a result of the conflict.

This, of course, is now becoming normalized as end-user industries are struggling to pass on the cost increase to their customers. The cost of logistics and global freight has also increased significantly.

For our basket of customers and the geographies they operate in, our costs have increased by 18% to 20% on global freight. Since late February, the sharp rise of prices in industrial fuel, our industrial fuel prices have increased by nearly 50%, and inconsistent retail availability has had a large bearing on our transportation costs driven by the fuel increases, which have gone up by approximately 50%.

Prices of other key commodities, Indonesian coal, sulfur, and propanol, have also been impacted unfavorably in the range of 20% to 30%. In a fairly demanding and difficult environment, despite these headwinds, our focus has been on the key areas I mentioned in the last earnings call: stabilizing our operations, especially in terms of bromine production; ensuring market growth, market share growth in industrial salt and derivatives; retaining our key customers in bromine; driving commercial and pricing actions; and doing aggressive cost reduction to mitigate the impact of these factors.

In this context, let me now cover the overall performance for the quarter and the full year on a stand-alone basis as well as some of our key subsidiary divisions. Industrial salt for the quarter volume for the quarter was 1.1 million tons, down 7.2% versus last year.

Volumes were impacted by nearly 120,000 tons due to customer deferrals on account of the US-Iran conflict and around 250,000 tons of shipments we could not complete because of logistics issues and challenges I mentioned earlier. For the full year, though, we had sales of 4.2 million tons, up by 22% from the previous year.

We had earlier shared that we estimated to meet around 4.5 million tons of shipments during the year, which has largely been impacted by the factors I just mentioned. Pricing in the quarter remained under pressure versus last year and was down by around 10%, but has been kind of stable versus the prior quarter.

Industrial salt has contributed 67% of the sales in the quarter we just completed, right, 67% of Q4 sales last year, and around 70% in FY '25-'26. Bromine volume, coming to bromine, bromine volume was at around 3,731 metric tons for the quarter.

It is up 53% from the quarter of the second quarter of '25-'26 and up by 4% versus the prior year. We continue to drive improvement recovery plan in production, and since mid-Feb, we have recovered our production levels to historical levels.

During the quarter, we continued to implement pricing actions with select customers and short-term contracts. Realization was up 14% year on year.

Overall, elemental bromine contributed to 32% of sales for Q4 last year and around 30% of the sales in Q4 FY of F'26. The bromine derivatives business, which is housed in Acuchem Chemicals Private Limited, continues to scale up.

Sales for the quarter were up by nearly 50% year on year, and revenue for the full year was up by nearly 300% compared to the previous year. While our margins remained under pressure due to the lower capacity utilization during this ramp-up phase, we estimate that our contribution margins will improve with new products and process optimization initiatives underway, supported by volume growth from some of our existing products like calcium bromide and NPBR.

During the quarter, we launched PBr3 and also continued to scale up our zinc bromide volumes for select customers. Capacity utilization for the quarter still remained at around 45%, and we continue to focus on driving that up.

SOP volumes in F'26 stood at 644 tons, contributing to a very small level of revenue of around ₹3.5 crores. As highlighted in earlier calls, there are complex technical issues for which we are now defining and kind of long-term solutions.

This involves re-engineering of the entire product system and the manufacturing process. This program is currently underway, and we expect to complete plant trials in the first quarter of this year and go into a higher level of production in the second half of the year.

As you're aware, we continue to scale up our operations in Ideals MudChem, earlier known as Oren Hydrocarbons. Over the past 12 months, we have commissioned three plants and are currently progressing with customer trials.

Our Gujarat plant is production-ready, but we still await necessary approvals from state authorities. For the Nagari plant in Andhra Pradesh, where we manufacture starch and PAC products, we are in the process of redefining the product road map to better align our product with market requirements.

We expect to have a fairly lean first half this year in terms of Ideals MudChem, but we expect that the second half will start getting to a larger ramp-up. The aforementioned issues on logistics costs have impacted the short-term profitability of the industrial salt segment.

However, our customer relationships and market position remain strong, and we estimate to see a full recovery in coming quarters with the completion of the highway projects and reduction in commodity and fuel costs as the Iran-US conflict subsides. Coming on to financial performance, to give you a quick summary of financial performance, total income for Q4 F'25-'26 stood at ₹304.7 crores, a 9% decrease on a year-on-year basis.

In terms of overall mix, bromine contributed 32% and industrial salt contributed 67%. Volume of sales of bromine, as I mentioned earlier, stood at 3,731 tons.

Volume of sales for industrial salt for the quarter was 1.1 million tons. Overall EBITDA stood reported was ₹66.4 crores, a 34.3% decline year on year.

EBITDA margin stood at 21.79% for the quarter, and profit after tax for Q4 FY '26 was at around ₹29.8 crores. The year-on-year decline in EBITDA was largely driven by the drop in pricing, or lower pricing realization, and lower volume, both of which happened in industrial salt.

We did also see an year-on-year increase in logistics cost, but that was largely offset by improvements in bromine, both in terms of realization as well as in terms of volume. In terms of full-year performance, total revenue for the year stood is reported at ₹1,088.8 crores, a 2% growth on a year-on-year basis.

EBITDA for the year stood at around ₹308 crores, a 17% dip on a year-on-year basis. Profit after tax for the year reported was ₹154.3 crores, a 17% decline year on year.

On a consolidated basis, total revenue for Q4 was at around ₹306.3 crores. The bromine derivative business contributed around ₹23.8 crores with a volume sale of around 1,400 tons for Q4.

EBITDA for the company overall stood at ₹49.1 crores in Q4 FY '26, and profit after tax on a fully consolidated basis was around ₹12.2 crores. From an FY '26 perspective, overall revenue is ₹1,108 crores.

Bromine derivatives business contributed around ₹81 crores, with volume sale of around 5,300 tons for the year. EBITDA for the company stood at ₹265 crores on a fully consolidated basis, with net profits of ₹105.4 crores.

A detailed breakup of the constituent elements of our consolidated performance has been provided in the earnings deck on our website for your review. Let me end my comments by summarizing our focus in the coming year and some reflections now that I've completed three months in my role.

As we look forward, I think we have established three clear strategic priorities for the company. The first one is consolidate this core salt and bromine business; secondly, to scale up our derivatives, oilfield, and SOP businesses; while we continue to invest in long-term opportunities and advanced materials for batteries and semiconductors.

The underlying focus of these priorities is to ensure that we are driving earnings quality, while also ensuring effective capital allocation across the business. We are delivering these driving these priorities through four strategic levers: driving focused growth, where we drive scale and volume in all businesses through differentiated products, long-term customer partnerships, and commercial excellence; the second one is operational excellence, driving productivity and growth in all our operations, especially on bromine, SOP, derivatives, and developing a world-class logistics capability while ensuring capital efficiency; thirdly, responsible stewardship in terms of driving an inclusive and empowered organization, focusing on sustainability and supporting local communities; and lastly, technology and automation to drive increased efficiency, reduce our cost to serve, and drive agility and predictability across our business.

Together, as we look across these four levers, and we believe that we will continue to drive volume growth in the core business, and as we start getting some of the external factors on cost stabilizing, we should be able to get to a historical margin level of performance across the business. With this, I'll open it for Q&A.

Operator

Thank you very much, sir. Ladies and gentlemen, we will now begin with the question-and-answer session.

Anyone who wishes to ask a question may enter star and one on the touch-tone telephone. If you wish to remove yourself from the question queue, you may enter star and two.

Participants are requested to please use only handsets while asking a question. We also request participants to please limit their questions to two questions per participant.

You may then rejoin the queue for follow-ups. We will wait for a moment while the question queue assembles.

The first question is from the line of Sanjesh Jain from ICICI Securities. Please go ahead.

Rampraveen Swaminathan

Good afternoon, Sanjesh.

Good afternoon, sir. Thanks for the opportunity.

I got few of the questions. First on this freight thing, the entire long route and the higher fuel cost, how much it did really hurt in terms of the cost during the Q3, sorry, in terms of the Q4 earnings?

That's number one. Number two, bromine prices globally has gone up sharply.

I know we have a long-term contract, but just to understand, how should we see the bromine prices for next year? In your opening remark, you mentioned that we have reached the historical peak of bromine production.

I think historically, quarterly, we were at 5,500 metric ton. This quarter, we are at 3,700.

When we say that we have reached the peak, do we imply that we are touching that 5,500 kind of a production? An added question to that, we have put up a blue area where we are looking to expand the brine pond, and we said that this will only enhance the production.

Now including that, what is the peak production we are looking up, and will it come in FY '27 or FY '28? These are my initial questions.

Thanks.

Rampraveen Swaminathan

Sanjesh, I will take them in whichever order which I find I can remember them, and if I do slip a question, please do kind of remind me again. I think firstly, as far as the logistics cost is concerned, I think, simplistically put, there are three phases.

January was pretty lean. We didn't have a big big issue in Jan.

In Feb, as you've seen, we had a significant increase because of the road route change, and that added nearly ₹100 to ₹120 per ton of cost. In the third month, we had both the diesel price increase and the extended route.

We ended the quarter with roughly around ₹200 to ₹220 per ton an increase of cost of transportation. Okay?

On a weighted average basis, across the quarter, probably around ₹14 to ₹15 crores was the impact because of the higher logistics cost, right, across the three months. That's kind of the net gross number.

I think as far as your second question was concerned in terms of bromine production, yes, I think, as I said, we've come back to historical levels on a daily rate. I think our historical peak, I'm talking from memory, was 5,230-odd tons in a quarter.

That quarter was a 91-day quarter or something. Roughly, it would be around 54, 55 tons per day.

We are roughly getting back to that range right now in terms of daily production. Okay?

Now I just would state here that when you look at modeling it out or forecasting it out, obviously, there are scheduled downtimes, etc., which do impact that a little bit, but we are in that range right now, okay, just confirming that.

Broadly 20,000, yeah,

Rampraveen Swaminathan

we are looking at

20,000, 21,000 metric ton in FY '27 if we sustain, say, 55 ton per day.

Rampraveen Swaminathan

If we sustain 55 or in that range, with a little bit of hit on the monsoon when it'll come down a little bit, we should be in the range which you mentioned.

Got it. Got it.

Rampraveen Swaminathan

As far as the third thing which you I think raised was around the brine field expansion. As we have been expanding the brine field.

We remain optimistic about long-term growth. We do expect that the salt business will continue to grow at 10% to 12%.

It's kind of bottomed out in terms of margins, in a large part because the cost increase we've had on logistics, but that's a structural cost which will go away. We have line of sight to that kind of ending to some extent.

We continue to be bullish on salt. The brine field expansion really will help us drive that 10, now 10% to 15% growth in capacity of salt.

Of course, will also allow us to be able to produce more liquor for bromine volume as well.

What are we looking at bromine then in an expanded capacity? Because we had an aim

Rampraveen Swaminathan

of

5,500. We are struggling at 20,000.

How should we look at the journey from here to the nameplate capacity?

Rampraveen Swaminathan

I think it's a big question, right, because there are multiple factors involved. I do think that we are expecting, or hoping to be able to grow 15%, 20% a year in terms of bromine production.

I think that's what we had mentioned last quarter as well. What I said last quarter, our next pit stop, if you may, is to try and get to 25,000 tons, and then beyond that to over a period of time to 40,000 tons.

Right? That's kind of what I would really still be anchoring our business on in terms of what we are trying to establish as goals for the company.

The 40,000-ton expansion, obviously, happens along with the derivatives business growth as well. It kind of happens hand in hand.

That's kind of where we're anchoring it at. Now is it sequential?

Is it year on year? There are multiple factors involved.

The brine fields themselves are being expanded now. It'll be six to nine months before we finish the expansion, and then an entire season before we actually fill the ponds and we actually have enough condensation, evaporation to be able to basically draw them out as liquor and as salt and crystallization.

It's a staged period, Sanjesh, but the key thing for us has been to start putting capacity ahead of demand and start making that move, and this is what we have tried doing right now.

Very clear. On the bromine pricing, because globally, bromine prices—

Rampraveen Swaminathan

Oh, yes, on the bromine pricing, yeah, sorry, I missed that question. Yes, I think, as I mentioned, we had a question last quarter as well, and probably had it earlier as well, and I mentioned that we are making pricing actions.

You've seen some impact of that in Q4 on a year-on-year basis, where we have increased the prices on our contracts. Obviously, prices went up in a short period of time very quickly.

I think as we look at currently, we have, I would say, renegotiated a very large part of our long-term contracts. Right?

I won't put a specific number on it, Sanjesh, but we have negotiated a very large part of our long-term contracts for this year. We've also gone back and reopened or rediscussed with customers on contracts which still had open windows on them and gone back and renegotiated some of them back as well.

Today, I think as we stand, a majority of our bromine contracts stand renegotiated upwards. I will not put a specific number on that, Sanjesh, but that's kind of directionally at least where we're going.

Got it. One one on the Acuchem, we had not a great year last year.

I thought the ramp-up expectation was much better than what we have delivered. What are the things which have not gone in our favor, and what are the measures we are taking to see that Acuchem really scales up to the level where probably which is more satisfactory?

Number two, what's the plan on the flame retardant? It's still under discussion, or it is rested for a while?

How should we see that?

Rampraveen Swaminathan

Okay. I think for Acuchem, there's no question that it has been a year where we've had growth, but we've not had the growth we expected, right?

I would say two, three things are the areas I think we have kind of been challenged with. I won't say they've been things that are necessarily done badly on, but they've just been challenged.

I think the first one has been product development. Some of our products, especially targeted towards pharma applications, have been a little bit longer cycle than we expected them to be, Sanjesh.

That's actually taken a little bit more time to get converted into specific orders and pull through. The second thing which has been a challenge has been in terms of commercial pricing.

I think we have had to work hard in getting pricing in there. You're an entrant into the market, you're entering in an established market where other players are there.

That obviously puts pressure on you on pricing, right? Probably we've been forced to have slightly more aggressive prices than we probably might have initially expected the same time last year.

The third thing which has been a challenge to some extent has been that obviously the Acuchem business gets its bromines from the Hajipir business, and some of our challenges in the second and third quarter on bromine production obviously translated into a ramp-up at that business as well. Okay?

What are we doing to fix that? We are fixing exactly the three things I spoke about now.

We have deepened our sales capability, we're expanding both in domestic and exports, our channel partnerships. We're also accelerating product development.

In Q4 alone, as I told you, we've upgraded the zinc bromide product, we've launched PBr3. We're looking at releasing a couple of more alkyl bromide products in the first half of this year.

Right? We've also been expanding on CBR, CaBr, and NPBr volumes, which obviously have large markets in terms of both the oilfield and the ag intermediate usage.

More market penetration, more product development, more consistent supply of bromine from the Hajipir plant, and lastly, we're working a lot in terms of process optimization and process costs, we actually have to kind of be able to drive that. I'm confident that I think you will see a significant improvement in the business as we drive that product utilization improvement starting in the early part of this year.

Very clear, sir. Just one last, sorry, I'm pushing it a little.

On the semiconductor, can you just help us the milestone from here to the production? What is the timeframe and the key milestone we need to track?

One—

Rampraveen Swaminathan

Rajeev, you want to take it? Yeah.

Rajeev Kumar

Sanjesh, let me take this question. We have started working on the design aspect, and the early work, we have already commenced.

Our target is to start the sub-structure work from July, and broadly, it should take 24 to 30 months from that time.

24 to 30 months from now or—

Rajeev Kumar

From July. Right.

From July. From July of last year, right?

Rajeev Kumar

July of this year.

Oh, from July of this year, we are looking at 24 to 30 months.

Rajeev Kumar

Yeah.

Rampraveen Swaminathan

Sanjesh, 20 So if you index the period from now to July, probably 27 to 30 months roughly is what it'll take.

Got it. Just one bookkeeping question, what was the SOP volume and revenue for this quarter?

Rampraveen Swaminathan

For this quarter, Sanjesh, I will have somebody drop you a note. I think I mentioned the full-year number, but it's okay.

I'll have somebody on our team, IR team, just

Full year is fine. What was the full year?

Rampraveen Swaminathan

Full year was ₹3.5 crores and 60 and 650 tons.

650 tons. That's

Rampraveen Swaminathan

664, I think, was the exact tonnage.

Okay.

Rampraveen Swaminathan

644 tons and ₹3.49 crores.

Thank you, sir. I think that is all from my side, and thanks for patiently answering all those questions, and best of luck for the coming quarters.

Rampraveen Swaminathan

Thanks, Sanjesh. Okay.

Operator

Thank you.

Rampraveen Swaminathan

Thank you.

Operator

The next question is from the line of Aditya Khetan from SMIFS Institutional. Please go ahead.

Thank you, sir, for the opportunity. Just a couple of questions.

Sir, you mentioned in your opening remarks on to the competitive intensity pressures. Is that the one of the reason why we are not able to increase the bromine prices?

Because, sir, when we look at the spot prices of bromine over the last three quarters versus Archean's realizations, there has been a stark difference. Actually, spot prices have gone up in one way.

Our realizations look almost flattish only when we look at the last two quarters' data also. Is it because of the competitive pressures which you mentioned, is that stopping the prices to move higher?

Secondly, sir, when I hear your commentary on to the bromine volume, you mentioned about some 10% to 15% growth. Sir, when we look at this number, 10% to 15% growth would still be around some 15, 16,000 tons only for FY '27 also versus what earlier management was guiding around 20, 22 22 to around 25k tons for FY '26.

There is a stark difference into the numbers which earlier management was guiding and what we are seeing for FY '27. Any thoughts of what has changed materially into the business?

Over to you. Aditya,

Rampraveen Swaminathan

let me answer these questions a bit more specifically. Firstly, I think on the bromine pricing, it's not a competitive intensity issue as much as the fact that, as we mentioned earlier as well, Aditya, we have a fairly large constituent of long-term contracts.

These are contracts we enter typically with annual pricing. Since we entered them with annual pricing, we generally don't change the pricing based on spot conditions too much.

So 70% to 80% let's say 70% of our business is long-term contracts, 30% of our business is short-term contracts, which is deal-to-deal pricing. Right?

Therefore, what you will always see is that when the prices go up, it takes us time to catch up. When the prices go down as well, we get the benefit because our customers continue to buy at the old prices from us.

Right? Therefore, what's happened the last 18 months is 15 months roughly, has been that prices have been inching up slowly till around February, when March, when prices went up substantially.

Right? We have taken the opportunity to go ahead of the curve this time in Feb and March and kind of even start renegotiating our contracts ahead of their closure.

That's why, as I mentioned to Sanjesh earlier on, when Sanjesh's question was there, we have repriced now a majority of our contracts upwards. Therefore, I think you will see that being different going forward.

That said, I think you must bear caution that spot prices are not a very good reflection of the overall blended price of the market. Typically, the entire industry on bromine works 60% to 70% on long-term contracts and 20% to 30% on short-term contracts.

When suddenly one one company suddenly has a shortage of bromine or has a production problem, then those customers that signed long-term contracts with them become spot customers in the market. They often buy at very, very high prices because they have to manage their end customer contracts.

Always spot prices are not a reflection of the blended average price for any company, and so we always encourage people to look at what people are reporting. Right?

Don't look at what the landed Shanghai index tells you or landed China index tells you, because there are short-term elements there, there's logistics pricing, there's transportation, there are multiple factors there. Broadly, we have gone back and renegotiated the majority of our customer basket.

You should see some of that pulling through. As far as your comment on the bromine volume, I think let me restate what I said.

Sanjesh's question was, are you back to the 55 tons per day level? I kind of said, yes, we are roughly at the 50, 55,000 tons per day level, which is around 20, 21,000 tons.

I said our goal next year is to probably 15% above that. Right?

This year is to be at that level, and next year is to be at around 15% above that, which gets close to that 25,000 tons number, which has been quoted earlier. Lastly, Aditya, on a lighter note, I would just like to tell you that the management has not changed.

The management has expanded. Right?

The earlier MD remains as the Executive Vice Chairman of the company, and therefore, the management has expanded. It has not changed.

We still are very much committed to the numbers which has been shared by Ranjit and others earlier.

Just one more question, sir, if I can squeeze in.

Rampraveen Swaminathan

Sir,

this quarter, we are seeing some ₹13 crore of increase into the stocks, which is reflected into the COGS. Can you highlight what this change is actually?

Secondly,

Rampraveen Swaminathan

sir, if

you can provide the internal sales volume of bromine for whole fiscal, FY '26, the captive consumption of bromine.

Rampraveen Swaminathan

I think the second one, I think I will have to get back to you. I don't have a specific number right now, Aditya.

If you can drop a mail to us, our team will respond, okay? As far as the first question is concerned, the ₹13 crores, I think, as I mentioned in my opening comments, we had initially also kind of hoped to do slightly higher volume of tonnage of salt in the quarter, and we're not able to do shipments because some orders got deferred, and also we had an issue where because of logistics cost, we could not fulfill those volume.

Therefore, finished salt inventory increased during the quarter, and that is a substantial part of what you see there as a increase in inventory cost.

Got it, sir. Thank you, sir.

Thanks.

Rampraveen Swaminathan

All right, thank you.

Operator

Thank you. The next question is from the line of Avnish Tiwari from Vaikarya.

Please go ahead.

Hi. Am I audible?

Operator

Yes, sir. Please go ahead.

Rampraveen Swaminathan

Hi, Avnish. Please carry on.

Hi. Hi.

You're mentioning in context of bromine demand that it increased, and then because the end industry is not able to pass through the pricing, the demand sort of getting rationed out or getting normalized. Can you expand on that commentary, and will that be a hurdle for you?

You have already renegotiated the long-term contract, but if you can give us a color around your this 30% deal-by-deal business, how is the pricing there in relative to your long-term contract versus the spot, which I know is not real, is much higher? Is it in the middle of these two, spot versus a long-term contract, or more closer to your long-term contract?

These two areas if you can expand upon.

Rampraveen Swaminathan

Sure, Avnish. I think let me just start off with a probably more external facing number, which everybody likes to quote, but that's at least generally agreed.

I think, shortly after the crisis started, bromine prices went up to around 70 to 80,000 RMB. Right?

Which is almost $8 or $9 per kg. It went up that high because there was a sudden shortage of bromine in the of bromine supply in the market.

Our end users, like companies makes flame retardant, etc., has their supply contracts to honor, and so there was a sudden because of shortage of supply, they had to basically buy at whatever, and so spot prices went up. Obviously, what most of our end customers are finding is that that is not sustainable for them to price it to their users.

Therefore, there has been some softening in terms of their end users pushing back and not accepting price increases, and that coming back through the chain to us as well. Therefore, there's some amount of softening, and today, if you look at it, I think prices have come back to around $5 per kg, 4.5, $4, $4.5 per kg.

Then depends on how much transportation, etc., you consider and how logistics is. Right?

You have these things seesawing because of that issue, and you must remember we make an intermediate which goes into a product which then goes to an end user. Right?

The entire value chain has to absorb the price increase. The first increase that happened was a supply-led increase or driven by supply shortage.

That is normalizing itself because that price is not being passed through fully. Okay?

That said, I do believe that our prices will reflect the broad movement in terms of market pricing going forward. Okay?

Right? Did that answer your question?

That's good.

Rampraveen Swaminathan

Thank you.

You were also mentioning that this short-term deal-by-deal pricing, is this more closer to the long-term pricing or this more closer to the spot, which is $4-$9 [unclear] per kg?

Rampraveen Swaminathan

In general, short-term pricing is closer to spot.

Okay?

Rampraveen Swaminathan

Obviously, long-term pricing is driven by multi-year relationships we have, end markets we want to play with. We don't want to have geographic concentration in one geography.

There are multiple considerations, Avnish. Now what does the end-user industries, flame retardant, right, pharma, etc., we want to position our product in, an oilfield chemicals, what's still the geographical diversification we want to have, right, what is the customer concentration in terms of what's the synergy benefit a customer brings across bromine, across derivatives.

There are multiple factors, but spot is definitely closer to market.

The second question which I have is that if you look at your supply shortage, you said has now reduced. This other supply of bromine which comes from locations which are under stress right now, has that supply now normalized, or that supply is still not normalized?

Rampraveen Swaminathan

I think that supply is still trailing probably what the past levels were. It is still trailing that, obviously, because there have been challenges.

New supply routes have emerged. Right?

I would still say that there's still a gap in the market demand-supply.

Israel supply, has it been affected, or that Jordan-Israel has not been impacted that much?

Rampraveen Swaminathan

To be fair, yeah, it would probably be unfair to just speak about specific geography, because in each geography, there are large companies which are at play and large players. I would say, generally, I think we look at trade route volume, Avnish, I think there is still a gap, right, on those trade routes compared to some of the volumes pre-conflict.

Okay. There is still a shortfall, and demand rationing is what is bringing the prices down.

Otherwise, it would have been much higher price, right, effectively?

Rampraveen Swaminathan

No, well, again, the point you must understand that because most of the industry works on long-term contract pricing, whenever there's a small dip in shortage, and also sells long-term. Capacity gets sold and blocked on a long-term basis.

Effectively, spot capacity, which gets traded all the time, is only 20% or 25% of overall capacity. If one manufacturer suddenly Right?

That's the impact which happens.

Okay. If I can squeeze one more.

If you were to look at your numbers, stand-alone versus consolidated, and there's a loss sitting between these two because of this other businesses you have, can you articulate where these numbers might go, let's say, in terms of EBITDA or revenue in one or two two years' time? I know you mentioned a lot of steps you are taking to bring

Rampraveen Swaminathan

No, Avnish, as we don't make forward-looking statements. I'll take an exception on that.

We're not going to give I won't be give specific guidance on those.

In the past, have you given the guidance around break-even points, when you can achieve there or what metrics we can track of all this? No,

Rampraveen Swaminathan

no, we don't provide specific guidance to that level of detail, Avnish.

Okay. Will you

Operator

last— Mr. Tiwari, please return to the queue.

Thank you. Participants, please limit your questions to only two questions.

We have several participants awaiting their turn. The next question is from the line of Chirag from Keynote.

Please go ahead.

Rampraveen Swaminathan

Hi, Chirag. Good afternoon.

Operator

Yes, Chirag, please go ahead.

Yes, thank you for the opportunity. Sir, first of all, I would like to understand the reason for significant volatility that is taking place in bromine prices.

It has went up from almost $5,000 per ton to almost $9,000, $10,000, and now reverting back to almost $7,000, if I'm not wrong. Just wanted to understand what actually brings such kind of volatility in the market.

Rampraveen Swaminathan

Why don't you just share all your questions, I'll answer them all together.

Sure. My second question is related to, as crude prices have started inching up from the earlier $55 per barrel rate, are we seeing new drilling activities taking place due to which the MudChem, the Oren Hydrocarbons business is actually starting seeing some new revenue to come into picture from this particular area?

There are some bookkeeping questions. One is what actually comes into intangible asset under development that is highlighted in our balance sheet?

Were there any revaluation taken place on raw material levels?

Rampraveen Swaminathan

I'll answer the first two, and I'll get Natarajan to answer the next two, right? I think what drives bromine pricing, as I mentioned a couple of times, the way the broad in the industry works is that basically the buyers and sellers in the industry tend to work on long-term contracting for a large part of their requirements or their large part of their production.

Therefore, what happens is that majority of the market still transacts on that long-term pricing. Right?

For example, if you and I have a contract, and we have signed a contract, let's say, at $3.50 per ton, and you signed for 75% of your volume requirement, and I signed for 75% of my capacity, that volume still transacts at a long-term price of. What happens is that there's a sudden imbalance which comes either because of sudden spike in demand or sudden shortage of supply, then that puts pressure on the market, and that pressure gets concentrated around the spot business.

If there's a sudden shortage in supply which happens, then what happens is that you have to go and still buy your bromine from somewhere. You tend to go and buy your balanced bromine, which I'm not supplying on the long-term contract, at whatever price you think you can afford.

That pushes the prices up. Right?

Therefore, what the industry tends to hear as volatile prices is basically only spot prices. Spot is a fraction of the market.

Right? We try and make effort to consistently remind that spot is only a fraction of the market, but that's actually where you see all the volatility.

You don't see a volatility in the majority of the market where there's a lot of movement happening. Okay?

That's the question around that. Natarajan, you want to talk about revaluation?

Natarajan Ramamurthy

Rajiv will explain, yeah. The second question, which was intangible asset under development.

SiCSem actually is doing a pilot line for wafer manufacturing at IIT Bhubaneswar. Whatever capital we have spent there so far is under intellectual property development.

At the same time, there is a technology transfer agreement with Clas-SiC Wafer Fab. The expenditure committed towards that so far is also under IAUD.

Got it. The two more questions, one, crude price movement, are we seeing any positive developments related to trials for MudChem?

Second was related to revaluation of—

Rampraveen Swaminathan

I think MudChem, I'm sorry, I missed that question, but I think right now, oil and gas demand is still fairly muted because a lot of that space in the Middle East, and therefore, I don't think we have seen anything tangibly move in terms of short-term demand. I think the view is that once the war subsides, then obviously, we go to reconstruction phase and should give us a flip in terms of demand.

Got it. Sir, related to that, any revaluation on inventory, because there is a significant shortfall?

Is it just for coal and sulfur or—

Natarajan Ramamurthy

No revaluation on the inventory.

What would be our CapEx, our debt level, what kind of debt level are we comfortable with at company level?

Rampraveen Swaminathan

We don't make a specific view like that. Our view is that capital discipline is about investing in projects which have got good returns.

We are growth-oriented, and therefore, we will continue to look at investing in high-growth, return projects, which also means that we have to scale up our existing businesses and deliver the right level of returns from them. Fair enough, sir.

Sir, one thing, the—

Operator

I'm sorry, sir. Please return to the queue, Chirag.

Thank you. Sure, sir.

I'll be back.

Operator

Thank you. The next question is from the line of Rohit Nagraj from 360 ONE Capital.

Please go ahead.

Thanks for the opportunity. Sir, I'll ask the all the questions together.

First is on the bromine pricing. I understand that the long-term contracts could be either calendar year or financial year, and probably both would have consummated for the next year.

What is the kind of pricing range that we are looking at? I'm not looking at a specific number, but a range would be helpful in terms of building in for the estimates.

Second thing, on Oren Hydrocarbon, we when we acquired, we had an estimate of ₹150 crores of revenues. When are we likely to reach that mark?

Any timelines would be broader timelines should be helpful. Third is in terms of industrial salt, you said there is pricing pressure.

I was unable to get the exact point because, anyways, it's an export-oriented business, and the realizations in terms of dollar terms are certainly I mean in rupee terms, certainly would be better because of the depreciation. Last one, bookkeeping question, what is the cash as of 31st March on the books?

Thank you.

Rampraveen Swaminathan

All right. I'll ask Natarajan to answer the fourth question, but let me try and take the first three.

I'm going to avoid giving a range as well on bromine pricing. I think, as I mentioned, we have gone and renegotiated majority of our contracts, even if they were not expiring.

We have gone back and renegotiated almost all our LTCs off, right? We've gone back and spoken to customers, and mentioned that we'll do this in the earlier call as well.

We have kind of completed a majority of that. Therefore, I think you will see the flow-through of it.

However, we usually don't give very specific guidance on pricing for reasons you very well understand, okay, right? Therefore, I would avoid giving a range as well.

As I said, you'll see flow-through impact as we've done that action. As far as Oren Hydrocarbons is concerned, I think we had given a guidance of ₹150 crores.

That was basically divided across three products: bentonite, which we make in the Mandvi plant in Gujarat; barite in a plant in Kodur; and the third one has been around starch and PAC products, which we make in a plant in Andhra Pradesh, in a location called Nagari. Around 40% to 45% of our volume was supposed to come from the bentonite product in Mandvi.

That plant actually we have to work with government on getting licenses cleared and approvals done. Unfortunately, the Gujarat government interprets some of the NCLT provisions or orders in a slightly different way, and we are working with the local government authorities to get aligned on that, which is right now, the hindrance in starting the plant up.

Right? That's actually what's affecting that.

The remaining part of the business, which was around half that ₹150 crores which we indicated, right, we have some challenges on retuning the product line. The markets have obviously changed.

Therefore, the target product composition is slightly different. We have developed new products in those plants.

Those products are actually under customer trials now. Obviously, those products are highly focused on the oil and gas market.

Given the situation that's happened recently and the crisis now, I'm not sure when we will actually see a recovery there. As we go to this year, in the second half of the year, right now, we hope that basis where we are executing right now on various fronts, we expect that at least two out of the three plants will be in operations at reasonable volume in the second half of the year.

Just on industrial salt, I think the way I can look at this, Rohit, a lot of our salt goes into South Asia and Southeast Asia. Right?

As in salt, the further you go away from India, the less competitive you are. Right?

Where we sell to markets in South Asia for high-grade applications where this requirement for NaCl content is very high, where the customer is willing to pay a premium for low insolubles, we actually get very good pricing. When you go into some of the other geographies like China, we are competing also with locally manufactured salt, and salt comes from other geographies which are geographically far closer to their end market.

Therefore, we get more pressure on pricing because of that. Right?

That was my reference to my earlier comments saying that, obviously, there's competitive intensity. It's by geography, it's different.

The competitive intensity in each geography determines the weighted average of our pricing in our basket. There are long-term customers where we have not seen price coming down too much because they are, let's say, in Indonesia or close or they're in an application where they need a very high-quality salt.

Then there are customers who are very far away from India, and who are ready to use a slightly lower quality salt in their application, and there we see more pricing pressure. Right?

That's kind of the balance which is there, and that's what drives broadly the contours of pricing in the market. Okay?

Obviously, if demand in those geographies or those customers that are growing very fast, we see benefits. They're not growing, we obviously see an impact of that as well.

Okay? With that, let me just let Natarajan answer the bookkeeping question.

Natarajan Ramamurthy

The standalone cash, cash equivalent, bank balance is ₹37 crore, and consolidated is ₹55 crore.

Sure. Thanks for answering all the questions, and all the best, sir.

Operator

Thank you. Due to time constraints, that was the last question.

I now hand the floor over to the management for closing comments.

Rampraveen Swaminathan

All right. Thank you, everyone, for joining us in the earnings call.

We appreciate your time and for showing interest in the company. In case of any queries, you can get in touch with our team or with SGA, our Investor Relations advisor.

We will turn back those questions very quickly. Right?

We look forward to meeting all of you over the next call. As a point of interest, we have scheduled the date for the AGM, right, which is on June 12th.

Hopefully, those of you who are able to make it, we'd love to have some of you members join us at the AGM as well. All right.

Thank you very much. Take care.

Stay safe.

Operator

Thank you very much, sir. On behalf of Archean Chemical Industries Limited, that concludes this conference.

Thank you for joining us, and you may now disconnect your lines. Thank you.